Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
CUPID: Cannabinoid Use in Progressive Inflammatory brain Disease
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases.
The control of reactive oxygen species production by SHP-1 in oligodendrocytes.
Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.
Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis.
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.
Elan provides update post restructuring announcement of Tysabri collaboration
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
Opexa Therapeutics Announces Tcelna™ as New Brand Name for MS Therapy
Factors associated with health-related quality of life among older people with multiple sclerosis.
[Non-medicinal treatments of spasticity in multiple sclerosis].
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis.
The role of mast cells in neuroinflammation.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Preliminary Investigation of Gait Initiation and Falls in Multiple Sclerosis.
PLZF Regulates CCR6 and Is Critical for the Acquisition and Maintenance of the Th17 Phenotype in Human Cells.
Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.
Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis.
Cannabinoids decrease the th17 inflammatory autoimmune phenotype.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Pages
« first
‹ previous
…
238
239
240
241
242
243
244
245
246
…
next ›
last »